Trial Profile
Exploratory clinical trial of KIB-PCI in healthy Japanese children
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Jun 2016
Price :
$35
*
At a glance
- Drugs Influenza A virus H5N1 vaccines (Primary)
- Indications Influenza A virus H5N1 subtype
- Focus Pharmacodynamics
- Sponsors Daiichi Sankyo Company
- 03 Jun 2016 New trial record